Controversies in cardiac resynchronization therapy: Do sex differences in response exist?

Current Heart Failure Reports

Volumn 8, Issue 1, 2011, Pages 59-64

  Germany, Robin E ^b   Ripley, Toni L ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b NONE

Author keywords

Cardiomyopathy; Gender; Heart failure; Pacing; Resynchronization; Sex; Women

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; COMORBIDITY; DEFIBRILLATOR; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; MORBIDITY; MORTALITY; POPULATION; QRS COMPLEX; RISK FACTOR; SEX DIFFERENCE; SINUS RHYTHM; SUDDEN DEATH; TREATMENT DURATION; TREATMENT RESPONSE;

CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HEART FAILURE; HUMANS; MALE; SEX FACTORS; TREATMENT OUTCOME;

EID: 79551547773     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-010-0040-6     Document Type: Article

References (26)

1. A Heiat CP Gross HM Krumholz 2002 Representation of the elderly, women and minorities in heart failure clinical trials Arch Intern Med 162 1682 1688 10.1001/archinte.162.15.1682 12153370
2. H Ghanbari G Dalloul R Hasan, et al. 2009 Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure Arch Intern Med 169 1500 1506 10.1001/archinternmed.2009.255 19752408 This article began the discussion about the different effects of intracardiac devices in men and women.
3. P Santangeli G Pelargonio 2010 Della Russo A, et al.: Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systemic review and meta-analysis Heart Rhythm 7 876 882 10.1016/j.hrthm.2010.03.042 20380893
4. D Lloyd-Jones R Adams T Brown, et al. 2010 Heart disease and stroke statistics 2010 update Circulation 121 e46 e215 10.1161/CIRCULATIONAHA.109. 192667 20019324
5. KF Adams Jr JH Patterson WA Gattis, et al. 2005 Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis J Am Coll Cardiol 46 497 504 1:CAS:528:DC%2BD2MXmvVKnsrs%3D 10.1016/j.jacc.2005.02.091 16053964 (Pubitemid 41040292)
6. R Garg S Yusuf 1995 Overview of randomized trials of angiotensin- converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative group ACE inhibitor trials JAMA 273 1450 1456 1:STN:280:DyaK2M3jvFyrtw%3D%3D 10.1001/jama.273.18.1450 7654275
7. PB Adamson KJ Kleckner WL VanHout, et al. 2003 Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure Circulation 108 266 169 10.1161/01.CIR.0000083368.75831.7A 12860899 (Pubitemid 36899014)
8. S Cazeau C Leclerq T Lavergne, et al. 2001 Effect of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 873 80 1:STN:280:DC%2BD3M7nsV2ltw%3D%3D 10.1056/NEJM200103223441202 11259720 (Pubitemid 32224395)
9. WT Abraham WG Fisher AL Smith, et al. 2002 Cardiac resynchronization in chronic heart failure New Engl J Med 346 1845 1853 10.1056/NEJMoa013168 12063368 (Pubitemid 34603028)
10. GW Woo S Petersen-Stejskal JW Johnson, et al. 2005 Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE Study J Intervent Card Elect 12 107 113 10.1007/s10840-005-6545-3 (Pubitemid 40386293)
11. JB Young WT Abraham AL Smith, et al. 2003 Combined cardiac resynchronization and implantable cardioversion defibrillation in advance chronic heart failure JAMA 289 2685 2694 10.1001/jama.289.20.2685 12771115 (Pubitemid 37430139)
12. SL Higgins JD Hummel IK Niazi, et al. 2003 Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant tachyarrhythmias J Am Coll Cardiol 42 1454 9 10.1016/S0735-1097(03)01042-8 14563591 (Pubitemid 37267289)
13. MR Bristow LA Saxon J Boehmer, et al. 2004 Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2140 50 1:CAS:528:DC%2BD2cXktF2isrc%3D 10.1056/NEJMoa032423 15152059 (Pubitemid 38637994)
14. LA Saxon MR Bristow J Boehmer, et al. 2006 Predictors of sudden cardiac death and appropriate shock in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial Circulation 114 2766 2772 10.1161/CIRCULATIONAHA.106.642892 17159063 (Pubitemid 46018278)
15. JGF Cleland JC Daubert E Erdman, et al. 2005 on behalf of the CARE-HF Study Investigators: The effect of cardiac resynchronization on morbidity and mortality in heart failure New Eng J Med 352 1539 1549 1:CAS:528: DC%2BD2MXjtFGnsLo%3D 10.1056/NEJMoa050496 15753115 (Pubitemid 40517094)
16. C Daubert MR Gold WT Abraham, et al. 2009 Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (resynchronization reverses remodeling in systolic left ventricular dysfunction) trial J Am Coll Cardiol 54 1837 1846 10.1016/j.jacc.2009.08.011 19800193
17. AJ Moss JW Hall DS Cannom, et al. 2009 Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 1329 1338 10.1056/NEJMoa0906431 19723701 This article showed that resynchronization therapy was beneficial even in patients with early stage heart failure. It also showed a strong effect in women at this stage
18. A Lilli G Ricciardi M Cristina Porciana, et al. 2007 Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling PACE 30 1349 1355 17976098
19. O Zardkoohi V Nandigam L Murray, et al. 2007 The impact of age and gender on cardiac resynchronization therapy outcome PACE 30 1344 1348 17976097
20. GB Bleeker MJ Schalij E Boersma, et al. 2005 Does a gender difference in response to cardiac resynchronization therapy exist? PACE 28 1271 1275 16403158
21. J Rickard DJ Kumbhani B Baranowski, et al. 2010 Usefulness of cardiac resynchronization therapy in patients with Adriamycin-induced cardiomyopathy Am J Cardiol 105 522 526 1:CAS:528:DC%2BC3cXhs1Ogsbo%3D 10.1016/j.amjcard.2009.10. 024 20152248
22. SD Solomon E Foster M Bourgoun, et al. 2010 Effect of Cardiac Resynchronization Therapy on Reverse Remodeling and Relation to Outcome Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy Circulation 122 985 992 10.1161/CIRCULATIONAHA.110. 955039 20733097
23. WB Kannel PW Wilson RB D'Augostino J Cobb 1998 Sudden cardiac death in women Am Heart J 136 205 212 1:STN:280:DyaK1czmvVekug%3D%3D 10.1053/hj.1998. v136.90226 9704680 (Pubitemid 28368840)
24. GC Fonarow NM Albert AB Curtis, et al. 2010 Improving evidence based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the use of Evidence-Based Heart Failure Therapies in the Oupatient Setting (IMPROVE HF) Circulation 122 585 96 10.1161/CIRCULATIONAHA. 109.934471 20660805 This article prospectively looked at outpatient adherence to recommended guidelines. It showed the benefit to patients of simple reminders of an indication in a specific patient
25. J Alaeddini MA Wood MS Amin, et al. 2008 Gender disparity in the use of cardiac resynchronization therapy in the United States PACE 31 468 472 18373766
26. DS Lee P Gona RS Vasan, et al. 2009 Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute Circulation 119 3070 77 10.1161/CIRCULATIONAHA.108.815944 19506115